Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Bruton's Tyrosine Kinase Targeting in Multiple Myeloma.
Int J Mol Sci. 2021 May 27;22(11):5707. doi: 10.3390/ijms22115707.
Int J Mol Sci. 2021.
PMID: 34071917
Free PMC article.
Review.
Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma.
Al-Odat O, von Suskil M, Chitren R, Elbezanti W, Srivastava S, Budak-Alpddogan T, Jonnalagadda S, Aggarwal B, Pandey M.
Al-Odat O, et al.
Front Pharmacol. 2021 Jul 19;12:699629. doi: 10.3389/fphar.2021.699629. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34349655
Free PMC article.
Review.
Item in Clipboard
Development of a novel Bruton's tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cells.
Elbezanti WO, Al-Odat OS, Chitren R, Singh JK, Srivastava SK, Gowda K, Amin S, Robertson GP, Nemmara VV, Jonnalagadda SC, Budak-Alpdogan T, Pandey MK.
Elbezanti WO, et al. Among authors: al odat os.
Front Pharmacol. 2022 Sep 9;13:894535. doi: 10.3389/fphar.2022.894535. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36160379
Free PMC article.
Item in Clipboard
Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma.
Al-Odat OS, Guirguis DA, Schmalbach NK, Yao G, Budak-Alpdogan T, Jonnalagadda SC, Pandey MK.
Al-Odat OS, et al.
Int J Mol Sci. 2022 Dec 30;24(1):644. doi: 10.3390/ijms24010644.
Int J Mol Sci. 2022.
PMID: 36614089
Free PMC article.
Review.
Item in Clipboard
Cite
Cite